{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05046613",
            "orgStudyIdInfo": {
                "id": "BHV3000-402"
            },
            "secondaryIdInfos": [
                {
                    "id": "C4951005",
                    "type": "OTHER",
                    "domain": "Alias Study Number"
                }
            ],
            "organization": {
                "fullName": "Pfizer",
                "class": "INDUSTRY"
            },
            "briefTitle": "Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant",
            "officialTitle": "A Prospective, Registry-based, Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant: The Migraine Observational Nurtec Pregnancy Registry (MONITOR)",
            "acronym": "MONITOR",
            "therapeuticArea": [
                "Neurology"
            ],
            "study": "observational-study-to-assess-maternal-fetal-and-infant-outcomes-following-exposure-to-rimegepant"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-11-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2034-04-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2034-04-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-09-08",
            "studyFirstSubmitQcDate": "2021-09-08",
            "studyFirstPostDateStruct": {
                "date": "2021-09-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-11",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Pfizer",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "PPD, Part of Thermo Fisher Scientific",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of the study is to evaluate fetal, maternal, and infant outcomes through 12 months of age."
        },
        "conditionsModule": {
            "conditions": [
                "Migraine"
            ],
            "keywords": [
                "Migraine, Migraine Headache, Pregnant, Pregnancy, Infant"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 780,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Pregnant women with migraine exposed to Rimegepant",
                    "description": "Pregnant women with a diagnosis of migraine who are exposed to rimegepant at any time during pregnancy or just prior to pregnancy (up to 3 days prior to conception)",
                    "interventionNames": [
                        "Other: Rimegepant"
                    ]
                },
                {
                    "label": "Pregnant women with migraine not exposed to Rimegepant",
                    "description": "Pregnant women with a diagnosis of migraine who are not exposed to rimegepant (up to 5 product half-lives prior to conception) but who may be exposed to other products for the treatment/prevention of migraine at any time during pregnancy or just prior to pregnancy",
                    "interventionNames": [
                        "Other: Not taking Rimegepant"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Rimegepant",
                    "description": "75mg",
                    "armGroupLabels": [
                        "Pregnant women with migraine exposed to Rimegepant"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Not taking Rimegepant",
                    "description": "No rimegepant",
                    "armGroupLabels": [
                        "Pregnant women with migraine not exposed to Rimegepant"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Major congenital malformation (birth defect)",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Minor congenital malformation",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                },
                {
                    "measure": "Gestational hypertension",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                },
                {
                    "measure": "Pre-eclampsia",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                },
                {
                    "measure": "Eclampsia",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                },
                {
                    "measure": "Gestational diabetes",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                },
                {
                    "measure": "Spontaneous abortion",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                },
                {
                    "measure": "Stillbirth",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                },
                {
                    "measure": "Elective termination",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                },
                {
                    "measure": "Preterm birth",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                },
                {
                    "measure": "Small for gestational age",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                },
                {
                    "measure": "Postnatal growth deficiency",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                },
                {
                    "measure": "Infant developmental delay",
                    "description": "Healthcare provider report through the registry",
                    "timeFrame": "Annually beginning April 2022"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Pregnant women with migraine exposed to rimegepant: a diagnosis of migraine and at least 1 dose of rimegepant during pregnancy or just prior to pregnancy (up to 3 days prior to conception)\n* Pregnant women with migraine unexposed to rimegepant: a diagnosis of migraine and no exposure to Rimegepant before or during pregnancy\n\nExclusion Criteria:\n\n\u2022 Women exposed to other calcitonin gene-related peptide (CGRP)antagonists (e.g., ubrogepant), CGRP monoclonal antibodies, or ditans (e.g., lasmiditan) at any time during pregnancy or just prior to pregnancy",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "genderBased": true,
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "The study population will include pregnant women of any age within the US with migraine who were treated with rimegepant as part of routine care at any time during pregnancy or just prior to pregnancy (up to 3 days prior to conception), as well as pregnant women with migraine not exposed to rimegepant before or during pregnancy.",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Pfizer Pfizer CT.gov Call Center",
                    "role": "CONTACT",
                    "phone": "1-800-718-1021",
                    "email": "ClinicalTrials.gov_Inquiries@pfizer.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Pfizer CT.gov Call Center",
                    "affiliation": "Pfizer",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "PPD",
                    "status": "RECRUITING",
                    "city": "Morrisville",
                    "state": "North Carolina",
                    "zip": "27560",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kristin Veley, PharmD, MPH",
                            "role": "CONTACT",
                            "phone": "877-366-0324",
                            "email": "nurtecpregnancyregistry@ppd.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.82348,
                        "lon": -78.82556
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "To obtain contact information for a study center near you, click here.",
                    "url": "https://pmiform.com/clinical-trial-info-request?StudyID=BHV3000-402"
                },
                {
                    "label": "Nurtec Pregnancy Registry",
                    "url": "https://nurtecpregnancyregistry.com/"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008881",
                    "term": "Migraine Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000051270",
                    "term": "Headache Disorders, Primary"
                },
                {
                    "id": "D000020773",
                    "term": "Headache Disorders"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9351",
                    "name": "Headache",
                    "relevance": "LOW"
                },
                {
                    "id": "M11852",
                    "name": "Migraine Disorders",
                    "asFound": "Migraine",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22529",
                    "name": "Headache Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M26657",
                    "name": "Headache Disorders, Primary",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                }
            ]
        }
    },
    "hasResults": false
}